Literature DB >> 9045711

Intragenic complementation at the human argininosuccinate lyase locus. Identification of the major complementing alleles.

D C Walker1, J Christodoulou, H J Craig, L R Simard, L Ploder, P L Howell, R R McInnes.   

Abstract

To determine the molecular and biochemical basis of intragenic complementation observed at the human argininosuccinate lyase (ASL) locus, we identified the ASL alleles in ASL-deficient cell strains with two unique complementation phenotypes: (i) frequent complementers, strains that participated in the majority of complementation events, and (ii) high activity complementers, strains in which complementation was associated with a relatively high level of restoration of ASL activity. Four mutations (Q286R, D87G, A398D, and a deletion of exon 13) were identified in the four strains examined. One of the two frequent complementers was homozygous, and the other heterozygous, for the Q286R allele. Similarly, one of the two high activity complementers was homozygous, and the other heterozygous, for the D87G allele. When the Q286R and D87G mutations were introduced by site-directed mutagenesis into wild-type ASL cDNA, each conferred loss of ASL activity in COS cell transfection assays. To test directly the hypothesis that intragenic complementation occurs at the ASL locus, one of the major complementation events observed previously, between strains carrying the Q286R and D87G alleles, was reconstructed in COS cell transfection assays. A partial restoration of ASL activity, comparable with the increase seen in the fibroblast complementation analysis, was observed on joint cotransfection of these two alleles. The results provide molecular confirmation of the major features of the ASL mutant complementation map, identify the Q286R and D87D alleles as the frequent and high activity complementing alleles, respectively, and provide direct proof of intragenic complementation at the ASL locus.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9045711     DOI: 10.1074/jbc.272.10.6777

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Two novel mutations (E86A, R113W) in argininosuccinate lyase deficiency and evidence for highly variable splicing of the human argininosuccinate lyase gene.

Authors:  M Linnebank; A Homberger; B Rapp; C Winter; T Marquardt; E Harms; H G Koch
Journal:  J Inherit Metab Dis       Date:  2000-06       Impact factor: 4.982

2.  Human argininosuccinate lyase: a structural basis for intragenic complementation.

Authors:  M A Turner; A Simpson; R R McInnes; P L Howell
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

3.  Clinical, enzymatic, and molecular genetic characterization of a biochemical variant type of argininosuccinic aciduria: prenatal and postnatal diagnosis in five unrelated families.

Authors:  W J Kleijer; V H Garritsen; M Linnebank; P Mooyer; J G M Huijmans; A Mustonen; K O J Simola; M Arslan-Kirchner; R Battini; P Briones; E Cardo; H Mandel; E Tschiedel; R J A Wanders; H G Koch
Journal:  J Inherit Metab Dis       Date:  2002-09       Impact factor: 4.982

4.  Bacterial expression of mutant argininosuccinate lyase reveals imperfect correlation of in-vitro enzyme activity with clinical phenotype in argininosuccinic aciduria.

Authors:  Katharina Engel; Jean-Marc Vuissoz; Sandra Eggimann; Murielle Groux; Christoph Berning; Liyan Hu; Vera Klaus; Dorothea Moeslinger; Saadet Mercimek-Mahmutoglu; Sylvia Stöckler; Bendicht Wermuth; Johannes Häberle; Jean-Marc Nuoffer
Journal:  J Inherit Metab Dis       Date:  2011-06-11       Impact factor: 4.982

5.  Functional consequences of PRODH missense mutations.

Authors:  Hans-Ulrich Bender; Shlomo Almashanu; Gary Steel; Chien-An Hu; Wei-Wen Lin; Alecia Willis; Ann Pulver; David Valle
Journal:  Am J Hum Genet       Date:  2005-01-20       Impact factor: 11.025

Review 6.  Optimizing therapy for argininosuccinic aciduria.

Authors:  Sandesh C S Nagamani; Brendan Lee; Ayelet Erez
Journal:  Mol Genet Metab       Date:  2012-07-20       Impact factor: 4.797

7.  Novel mutations underlying argininosuccinic aciduria in Saudi Arabia.

Authors:  Faiqa Imtiaz; Moeen Al-Sayed; Danyah Trabzuni; Bashair R Al-Mubarak; Osama Alsmadi; Mohamed S Rashed; Brian F Meyer
Journal:  BMC Res Notes       Date:  2010-03-18

8.  Functional complementation in yeast allows molecular characterization of missense argininosuccinate lyase mutations.

Authors:  Eva Trevisson; Alberto Burlina; Mara Doimo; Vanessa Pertegato; Alberto Casarin; Luca Cesaro; Placido Navas; Giuseppe Basso; Geppo Sartori; Leonardo Salviati
Journal:  J Biol Chem       Date:  2009-08-24       Impact factor: 5.157

Review 9.  Intragenic complementation at the argininosuccinate lyase locus: reconstruction of the active site.

Authors:  P L Howell; M A Turner; J Christodoulou; D C Walker; H J Craig; L R Simard; L Ploder; R R McInnes
Journal:  J Inherit Metab Dis       Date:  1998       Impact factor: 4.982

10.  From genotype to phenotype: Early prediction of disease severity in argininosuccinic aciduria.

Authors:  Matthias Zielonka; Sven F Garbade; Florian Gleich; Jürgen G Okun; Sandesh C S Nagamani; Andrea L Gropman; Georg F Hoffmann; Stefan Kölker; Roland Posset
Journal:  Hum Mutat       Date:  2020-01-30       Impact factor: 4.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.